China - News

The PCI team never stops innovating. Stay informed about our latest achievements.

Working Through the COVID-19 Crisis in API Manufacturing

Tags: Blog | CDMO | China | Drug Shortage

Posted April 14, 2020
Dealing with Tariffs and Other Uncertainties

Tags: API Manufacturing | Blog | CDMO | China | SEQENS

Posted August 26, 2019
The March of Chinese Biotech to the U.S. Can Become the Spark of Global Innovation for U.S. Firms

Tags: API Manufacturing | Blog | China | Training

Posted August 12, 2019
The Challenges and Opportunities for Generic Drug Makers

Tags: API Manufacturing | Blog | Brand Name Drugs | CDMO | China

Posted February 4, 2019
Generic API Margins Being Squeezed?

Tags: API Manufacturing | CDMO | China | GDUFA | Generic Drug Manufacturing

Posted January 14, 2019
Why Does the U.S. Continue to Lead the Contract Manufacturing Market?

Tags: API Manufacturing | Blog | China | Medical device

Posted June 22, 2018
Should you Use an Overseas Partner When Manufacturing Controlled Substances?

Tags: Blog | China | Controlled Substance

Posted October 12, 2017
Outsourcing Your API Manufacturing to Asia?

Tags: Articles | China | ICH | Pharmaceutical Outsourcing

Posted April 5, 2017
Outsourcing API Manufacturing to Asia: Pros, Cons, & Considerations

Tags: Blog | China | Comparison | Project Management

Posted January 17, 2017
Think CROs in China and India are cheaper? Here’s the real story.

Tags: Articles | China | Cost

Posted February 15, 2013